CC-2850

N/A

Report date: 2024/01/30 19:01:19
NME

Base Information

Drug NameCC-2850
Drug Alias NameCC-2850
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors
TargetsHepatitis C virus NS5B RNA-dependent RNA polymerase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCocrystal Discovery Inc
China Registration ClassN/A

Develop Information

Active CompaniesCocrystal Pharma Inc
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A